TheFiscalFinder
● Single award · contract

2017 Adult Flu

A single federal award, with both ends of the trail linked.
$90.9M
total award value
2016
action date
14 mo
period
HHSD200201792735C
PIID
Agency ›
Department of Health and Human Services
✓ from source
awarded→$90.9M
Recipient ›
Glaxosmithkline, LLC
✓ from source
performed in→
State ›
Georgia
✓ from source

Description

Igf:ot:igf 2017 Adult Flu

Awarding agencyDepartment of Health and Human Services →
RecipientGlaxosmithkline, LLC →
Place of performanceGeorgia →
CategoryNAICS 325411PSC 6505
Competed?Not recorded✓ from source
Total (exact)$90,859,489

More awards to Glaxosmithkline, LLC

COVID-19: Sotrovimab Monoclonal Andtibodies
awarded 2021$1.6B
Vacines for Children
awarded 2017$682.2M
Vaccine for Children (Vfc) 2014
awarded 2014$602M
Vacccine for Children 2012
awarded 2012$554.8M
Glaxosmithkline Adjuvant AS03
awarded 2020$335.6M
All awards to this recipient →

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
Medicaid Entitlement for 7 - Fy 2022 Quarter 4 - T19
awarded 2022$71.7B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.